CAVU Biotherapies, Inc.

CIK: 1696916DEIncorporated: 2015-07-22

Current Offering

$68,000
Target Amount
$1,000,000
Maximum Amount
2017-11-24
Deadline

Security Details

Type: SAFE (Simple Agreement for Future Equity)
Price per share: $1.00
Shares offered: 68,000+

Offering Costs

Cash commission: 4%
4.0% of the offering amount upon a successful fundraise.
Equity compensation: 0%
No

Financial Reports

Offering via Wefunder

Offering History

As of 2017-05-30
Raising $68,000 -$1,000,000 via 68,000+ shares of sAFE (Simple Agreement for Future Equity) at $1.00 per share
Deadline: 2017-11-24
Filing date2017-05-30
Current employees1
Act received most recent fiscal year$0.00
Act received prior fiscal year$0.00
Cash equi most recent fiscal year$6,419
Cash equi prior fiscal year$0.00
Cost goods sold most recent fiscal year$0.00
Cost goods sold prior fiscal year$0.00
Long term debt most recent fiscal year$6,000
Long term debt prior fiscal year$0.00
Net income most recent fiscal year-$66,978.00
Net income prior fiscal year-$35,570.00
Revenue most recent fiscal year$0.00
Revenue prior fiscal year$0.00
Short term debt most recent fiscal year$61,213
Short term debt prior fiscal year$14,399
Tax paid most recent fiscal year$4,500
Tax paid prior fiscal year$0.00
Total asset most recent fiscal year$6,419
Total asset prior fiscal year$0.00

Company Information

Corporation
DE
2015-07-22

Latest Metrics

Employees1
Total Assets$6,419
Cash on Hand$6,419
Revenues$0.00
Net Income-$66,978.00

Crowdfunding Portals

This company is raising funds through this portal